Literature DB >> 3089179

Hepatitis B virus infection in multitransfused haemophiliacs.

G Nebbia, G A Moroni, L Simoni, M Belli, V Carnelli.   

Abstract

A longitudinal study of 44 haemophilic children, all in a treatment programme with factor concentrates, was undertaken to evaluate the occurrence, characteristics, and evolution of hepatitis B virus (HBV) infection. Twenty four children (55%) (group I) showed signs of HBV infection, while 20 (45%) (group II) did not. Age at onset of treatment, number of infusions, and total amount of concentrate received did not show significant differences between the two groups. In group I only four children (16%) had symptomatic acute hepatitis. Chronic liver disease was present in nine patients (38% of infected children). The early age of infection would seem to be an important factor for predicting chronic evolution. Evidence of delta infection in three children with severe liver disease seemed to confirm the high pathogenicity of this agent. Because of the risks associated with chronic HBV infection a careful follow up of patients positive for hepatitis B surface antigen is mandatory.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089179      PMCID: PMC1777839          DOI: 10.1136/adc.61.6.580

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

2.  Addition of hepatitis-B immunoglobulin to clotting factor.

Authors:  C Scaroni; V Cancellieri; V Carnelli; G A Moroni; M Angeli
Journal:  Lancet       Date:  1980-09-06       Impact factor: 79.321

3.  Liver biopsy in hemophilia A.

Authors:  H R Lesesne; J E Morgan; P M Blatt; W P Webster; H R Roberts
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

4.  The high risk of chronic liver disease in multitransfused juvenile hemophiliac patients.

Authors:  J A Spero; J H Lewis; S E Fisher; U Hasiba; D H Van Thiel
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

5.  Hepatocellular enzyme patterns and hepatitis B virus exposure in multitransfused young and very young hemophilia patients.

Authors:  E D Gomperts; J Lazerson; D Berg; D Lockhart; E Sergis-Deavenport
Journal:  Am J Hematol       Date:  1981       Impact factor: 10.047

6.  The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen.

Authors:  M Rizzetto; J W Shih; J L Gerin
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen.

Authors:  M Rizzetto; C Morello; P M Mannucci; D J Gocke; J A Spero; J H Lewis; D H Van Thiel; C Scaroni; F Peyretti
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

8.  Hepatitis B virus, hepatitis A virus and persistently elevated aminotransferases in hemophiliacs.

Authors:  R J Gerety; M E Eyster; E Tabor; J A Drucker; C J Lusch; D Prager; S A Rice; H S Bowman
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

9.  Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease.

Authors:  H C Kim; P Saidi; A M Ackley; K A Bringelsen; D J Gocke
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

10.  Liver dysfunction in Pennsylvania's multitransfused hemophiliacs.

Authors:  U Hasiba; M E Eyster; F M Gill; M Kajani; J H Lewis; C J Lusch; D Prager; S A Rice; S S Shapiro
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.